ReviewKidney diseases (Basel, Switzerland)2024

Therapy Targeted to the NLRP3 Inflammasome in Chronic Kidney Disease.

Yong Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.